Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
A new class action lawsuit alleges that New Jersey supplement maker Nutrabio Labs falsely advertises its Glutamine products as being able to support muscle growth.
Lead plaintiff David Kim claims in the Nutrabio Labs Glutamine class action lawsuit that the products are “packaged and advertised as ‘Supports Muscle Growth’, ‘Speeds Muscle Recovery’, ‘L-Glutamine has powerful muscle building effects, promoting protein synthesis and inhibiting protein breakdown’, ‘Muscle Recovery Accelerator’, ‘Clinically Dosed’, and ‘Strength and Growth Matrix’.”
However, alleges the Nutrabio Labs Glutamine class action lawsuit, “Defendant, like many companies in the bodybuilding supplemental industry, ignore competent and reliable scientific data regarding their Products and ingredients and promote, market and represent the Products as providing benefits or enhancements which they cannot provide or deliver such as the representations made by Defendant about L-Glutamine in its Products.”
Kim claims he purchased the Glutamine supplements from Nutrabio Labs in 2017. He says he based his purchase off of statements on the product packaging in the Nutrabio Labs Glutamine class action lawsuit.
According to the Nutrabio Labs Glutamine class action lawsuit, L-Glutamine, also known as simply Glutamine, is an amino acid found in abundance in human blood.
It is “one of the individual building blocks that join together to make up proteins in the body,” states the Nutrabio Labs class action lawsuit.
However, Glutamine is made by the human body, so it is considered “non-essential,” meaning we don’t have to consume it as a part of our diet, alleges the Nutrabio Labs Glutamine class action lawsuit.
“While Glutamine naturally found within the body plays a role in certain mechanisms supporting muscle growth, recovery and immunity support, numerous scientific studies have proven that use of Glutamine supplements provides no additional benefits to the body,” alleges the Nutrabio Labs Glutamine class action lawsuit.
The Nutrabio Labs Glutamine class action lawsuit states that the company misleadingly advertises these unnecessary supplements to athletes and body builders, who often consume up to 40 grams of the substance each day.
“Basically,” states the Nutrabio Labs Glutamine class action lawsuit, “the ingestion of Defendant’s Products does absolutely nothing for the recovery from exercise, recovery of muscle tissue, increase in muscle growth or ability to decrease muscle wasting (anti-catabolic).”
The plaintiff accuses the New Jersey based supplement maker of being aware that it’s marketing claims are false and misleading. The Nutrabio Labs Glutamine class action lawsuit claims that the plaintiff and other consumers have suffered damages as a result.
The Nutrabio Labs Glutamine class action lawsuit seeks to represent a nationwide Class of consumers who purchased the supplements, as well as a Massachusetts subclass.
The Nutrabio Labs Glutamine class action lawsuit is seeking damages, as well as a court order stopping the supplement maker from making allegedly misleading marketing claims.
Kim is represented by Michael Weinkowitz and Charles E. Schaffer of Levin Sedran & Berman LLP; Nick Suciu III of Barbat Mansour & Suciu PLLC; Charles J. LaDuca and Beatrice Yakubu of Cuneo Gilbert & LaDuca LLP; and Erica C. Mirabella of Mirabella Law LLC.
The Nutrabio Labs Glutamine Class Action Lawsuit is Kim v. Nutrabio Labs Inc., Case No. 2:18-cv-11480-MCA-CLW, in the U.S. District Court for the District of New Jersey.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.